NCT00578331View on ClinicalTrials.gov

Safety Study of Olopatadine Nasal Spray

PHASE3CompletedINTERVENTIONAL

Enrollment

890

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG

Olopatadine 0.6% nasal spray

2 sprays each nostril twice daily

DRUG

Placebo Nasal Spray

2 sprays each nostril twice daily

Trial Locations (1)

76712

Waco, Waco

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY